|
MUDENG expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62492241884138E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.99200722162641E-16 |
| Normal-vs-Stage2 |
3.17599999966056E-07 |
| Normal-vs-Stage3 |
1.56680000085174E-08 |
| Normal-vs-Stage4 |
3.25419691193929E-11 |
| Stage1-vs-Stage2 |
9.812000E-01 |
| Stage1-vs-Stage3 |
7.130600E-01 |
| Stage1-vs-Stage4 |
4.273600E-02 |
| Stage2-vs-Stage3 |
7.879400E-01 |
| Stage2-vs-Stage4 |
1.719450E-01 |
| Stage3-vs-Stage4 |
1.892830E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
1.81110000330165E-08 |
| Normal-vs-Asian |
6.806100E-02 |
| Caucasian-vs-AfricanAmerican |
2.848600E-01 |
| Caucasian-vs-Asian |
6.546200E-01 |
| AfricanAmerican-vs-Asian |
9.511000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.11022302462516E-16 |
| Normal-vs-Female |
2.18602913548693E-13 |
| Male-vs-Female |
6.993400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.0398999983916E-09 |
| Normal-vs-Extreme_Weight |
1.11022302462516E-16 |
| Normal-vs-Obese |
1.52100554373646E-14 |
| Normal-vs-Extreme_Obese |
4.251800E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.390200E-01 |
| Normal_Weight-vs-Obese |
8.328200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.759200E-01 |
| Extreme_Weight-vs-Obese |
7.087200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.183400E-01 |
| Obese-vs-Extreme_Obese |
2.445200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.59320342976821E-11 |
| Normal-vs-Age(41-60Yrs) |
1.62758695410048E-12 |
| Normal-vs-Age(61-80Yrs) |
3.33066907387547E-16 |
| Normal-vs-Age(81-100Yrs) |
5.16889864243808E-11 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.136800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.039800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.515000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.538800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.199390E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.540960E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62436730732907E-12 |
| Normal-VS-Type2 PRCC |
8.15547629429147E-12 |
| Normal-VS-KIRP CIMP |
1.98585592414702E-12 |
| Normal-VS-Unclassified PRCC |
3.37380012815913E-10 |
| Type1 PRCC-VS-Type2 PRCC |
4.797000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.020100E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
6.582200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.432100E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
8.509400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.218980E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.55111512312578E-16 |
| Normal-vs-N1 |
9.38538136097122E-12 |
| Normal-vs-N2 |
1.21679999409707E-09 |
| N0-vs-N1 |
7.593800E-01 |
| N0-vs-N2 |
1.557700E-02 |
| N1-vs-N2 |
1.332260E-02 |
|
|
